Searching over 5,500,000 cases.

Buy This Entire Record For $7.95

Download the entire decision to receive the complete text, official citation,
docket number, dissents and concurrences, and footnotes for this case.

Learn more about what you receive with purchase of this case.


June 11, 1980


The opinion of the court was delivered by: LASKER

By consent decree of February 17, 1956 the defendants were enjoined

"from acquiring a beneficial interest in any theatre, provided that . . .
(B) . . . defendants may acquire a beneficial interest in any theatre
(1) . . . upon an affirmative showing to this court that such acquisition will not unduly restrain competition . . . ." (Consent Decree P XXV)

 Pursuant to those provisions the Shubert Organization, successor to the "Shubert defendants" as defined in Paragraph II(N) of the Consent Decree, moves for an order granting it permission to manage the National Theatre in Washington, D.C. *fn1" The application is granted. *fn2"

 On April 2, 1980, at the request of the Antitrust Division of the Department of Justice, Shubert published a notice in Variety inviting public comment on Shubert's motion for permission to manage the National Theatre. In response to that notice the Antitrust Division received 34 communications, all but two of which were favorable to Shubert's application. Among them were two comments from the management of theatres in Washington that compete with the National Theatre, four from other competing theatre operators, and five from labor organizations, including Actors' Equity Association, all of which expressed the belief that the Shubert Organization is qualified to manage the National Theatre, and that allowing it to do so would further competition among Washington theatres. Of the two adverse comments, the most forceful was that submitted by the Nederlander Theatrical Corporation and Alvin Nederlander Associates, Inc. ("Nederlander"), direct competitors of Shubert.

 The Antitrust Division has submitted a memorandum to the court which reviews the arguments proffered in opposition to Shubert's motion. *fn3" It advises the court that in the view of the Department of Justice granting the application would foster rather than restrain competition, that if Shubert were to attempt to use the right to manage the National Theatre to gain a competitive advantage, the injunctive provisions of the consent decree would provide an adequate remedy, and that accordingly the Department does not oppose Shubert's application. By letter to the court dated June 5, 1980, the attorneys for Nederlander responded to the Antitrust Division's memorandum, and by letters dated June 5, 1980 and June 9, 1980, respectively, counsel for Shubert and the Antitrust Division replied.

 Before disposing of the particular issues raised by the application and the objections to it, some general observations are in order. We believe that Nederlander mistakes the nature of this proceeding and the office of the court in the circumstances. This is not a plenary action in which the court sits as finder of fact ab initio, but an enforcement proceeding pursuant to a consent decree in which the court's function is limited to determining that the decree is observed. We conclude that Shubert has made the affirmative showing required by the decree, that permitting it to manage the National Theatre "will not unduly restrain competition."

 Moreover, Nederlander's arguments have been met and defeated. In its memorandum in response to the notice in Variety and in its informal submissions to the court, Nederlander argues that allowing Shubert to manage the National Theatre would restrain competition on a nation-wide basis, and that Shubert's past conduct "evidences a propensity" to violate the consent decree. The record demonstrates that the arguments are without merit.

 Nederlander's principal contention is that allowing Shubert to control the National Theatre would permit it to gain dominance in the "try-out" circuit of Boston, Philadelphia and Washington. Nederlander claims that the relevant market by which the question of adverse effect on competition should be determined consists of these cities, where New York shows are previewed, and New York itself. The Department of Justice argues that the Washington metropolitan area is the relevant market. The record on this issue understandably does not include the wealth of data to be found in the proceedings of a plenary antitrust case. However, we are satisfied that whichever is the relevant market, Shubert has made the requisite showing, and we are reassured by the Department of Justice's conviction that Washington is the relevant market and that Shubert's entry into the picture in Washington will stimulate rather than lessen competition. Even assuming that Nederlander's characterization of the relevant market is correct, its own statistics show that if Shubert were allowed to manage the National Theatre its control of first class theatres in Boston, Philadelphia and Washington which are the key "try-out" cities and in New York, would be increased by only 2.2%. This increase has not been shown to have an anti-competitive effect, and it pales in the face of the evidence of pro-competitive effects in Washington which others, including the Antitrust Division, suggest would occur were Shubert's application granted. *fn4"

 Nederlander also argues that Shubert has not in the past complied with the consent decree and consequently is not entitled to the relief which it seeks here. Nederlander recites three incidents in which it contends Shubert violated the decree. Shubert, however, has in each instance rebutted the suggestion that its conduct was inconsistent with the decree.

 First, Nederlander asserts that Shubert, "through the operation of the "non-profit' Shubert Foundation, has apparently used the leverage of the capital it has available for investment in productions in order to gain attractions for Shubert theatres." *fn5" In support of this contention, Nederlander alleges that the Foundation has, through contributions to Joseph Papp's New York Shakespeare Festival, induced or coerced the Festival to move its commercially successful productions into Shubert theatres on Broadway. However, Shubert has established that its contributions to the Shakespeare Festival are unconditional, and that they represent less than one-half of 1% of the Festival's revenues, a level of contribution that cannot be said to provide significant "leverage." Moreover, many beneficiaries of Shubert Foundation grants have presented Broadway productions at non-Shubert theatres with no lessening of the Foundation's subsequent levels of contribution.

 Second, Nederlander argues that Shubert has "taken over" Theatre Guild subscription lists in Chicago, Philadelphia and Boston, and "restricted access by subscribers in these cities to its theatres." *fn6" It appears, however, that the American Theatre Society, which provides subscription and promotional services under the aegis of the Theatre Guild, offered those services to Shubert, Nederlander and others. Shubert accepted the offer; Nederlander declined it. These services remain available to Nederlander and anyone else wishing to employ them. They have not been "taken over" by Shubert.

 Third, Nederlander asserts that Shubert induced the producers of "Annie" to book it into a Shubert Theatre in Los Angeles on terms less favorable than those offered by an independent theatre. However, the record indicates that the creative artists involved in "Annie" chose the Shubert Theatre over the other after considering the relative merits of both proposals before them, concluding unanimously "that for the long term success of the show, both financially and aesthetically, the Shubert Theatre is their clear choice." *fn7" Nothing but Nederlander's unsupported statement suggests that Shubert played an untoward role in the episode. Nederlander, a co-producer of "Annie", was aware of how the choice between the two theatres was made and the reasons given for ...

Buy This Entire Record For $7.95

Download the entire decision to receive the complete text, official citation,
docket number, dissents and concurrences, and footnotes for this case.

Learn more about what you receive with purchase of this case.